Cis-fumagillin, a new methionine aminopeptidase(yp 2) inhibitor produced by Penicillium sp. F2757

Cited 20 time in scopus
Metadata Downloads

Full metadata record

DC FieldValueLanguage
dc.contributor.authorJu Young Kwon-
dc.contributor.authorHa Won Jeong-
dc.contributor.authorHyae Kyeong Kim-
dc.contributor.authorKui Hyun Kang-
dc.contributor.authorYie Hwa Chang-
dc.contributor.authorKyung Sook Bae-
dc.contributor.authorJung Do Choi-
dc.contributor.authorUn Chul Lee-
dc.contributor.authorKwang Hee Son-
dc.contributor.authorByoung-Mog Kwon-
dc.date.accessioned2017-04-19T08:57:07Z-
dc.date.available2017-04-19T08:57:07Z-
dc.date.issued2000-
dc.identifier.issn0021-8820-
dc.identifier.urihttps://oak.kribb.re.kr/handle/201005/5116-
dc.description.abstractSelective inhibition against the yeast MetAP2 (methionine aminopeptidase type 2) was detected in the fermentation broth of a fungus F2757 that was later identified as Penicillium janczewskii. A new compound cis-fumagillin methyl ester (1) was isolated from the diazomethane treated fermentation extracts together with the known compound fumagillin methyl ester (2). The cis-fumagillin methyl ester, a stereoisomer of fumagillin methyl ester at the C2'-C3' position of the aliphatic side chain, selectively inhibited growth of the map 1 mutant yeast strain (MetAP1 deletion strain) at a concentration as low as 1 ng. However, the wild type yeast w303 and the mutant map2 (MetAP2 deleted) strains were resistant up to 10 μg of the compound. In enzyme experiments, compound 1 inhibited the MetAP2 with an IC50 value of 6.3 nM, but it did not inhibit the MetAP1 (IC50 >200 μM). Compound 2 also inhibited the MetAP2 with an IC50 value of 9.2 nM and 105 μM against MetAP1.-
dc.publisherSpringer-Nature Pub Group-
dc.titleCis-fumagillin, a new methionine aminopeptidase(yp 2) inhibitor produced by Penicillium sp. F2757-
dc.title.alternativeCis-fumagillin, a new methionine aminopeptidase(yp 2) inhibitor produced by Penicillium sp. F2757-
dc.typeArticle-
dc.citation.titleJournal of Antibiotics-
dc.citation.number8-
dc.citation.endPage806-
dc.citation.startPage799-
dc.citation.volume53-
dc.contributor.affiliatedAuthorHa Won Jeong-
dc.contributor.affiliatedAuthorHyae Kyeong Kim-
dc.contributor.affiliatedAuthorKyung Sook Bae-
dc.contributor.affiliatedAuthorKwang Hee Son-
dc.contributor.affiliatedAuthorByoung-Mog Kwon-
dc.contributor.alternativeName권주영-
dc.contributor.alternativeName정하원-
dc.contributor.alternativeName김혜경-
dc.contributor.alternativeName강귀현-
dc.contributor.alternativeName장이화-
dc.contributor.alternativeName배경숙-
dc.contributor.alternativeName최정도-
dc.contributor.alternativeName이운철-
dc.contributor.alternativeName손광희-
dc.contributor.alternativeName권병목-
dc.identifier.bibliographicCitationJournal of Antibiotics, vol. 53, no. 8, pp. 799-806-
dc.identifier.doi10.7164/antibiotics.53.799-
dc.description.journalClassY-
Appears in Collections:
Division of A.I. & Biomedical Research > Microbiome Convergence Research Center > 1. Journal Articles
Files in This Item:
  • There are no files associated with this item.


Items in OpenAccess@KRIBB are protected by copyright, with all rights reserved, unless otherwise indicated.